Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia · Delayed Price · Currency is MYR

1.330

+0.030 (2.31%)

At close: Apr 8, 2026

Revenue by Segment

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing and Distribution of Pharmaceutical Products	931.69M	813.70M	704.73M	696.72M	639.18M
Manufacturing and Distribution of Pharmaceutical Products Growth	14.50%	15.46%	1.15%	9.00%	12.16%
Total	931.69M	813.70M	704.73M	696.72M	639.18M
Total Growth	14.50%	15.46%	1.15%	9.00%	12.16%

Revenue by Geography

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Malaysia	871.83M	754.18M	650.55M	654.89M	596.89M
Malaysia Growth	15.60%	15.93%	-0.66%	9.72%	13.60%
Export	59.87M	59.51M	54.18M	41.83M	42.29M
Export Growth	0.59%	9.84%	29.53%	-1.09%	-4.92%
Total	931.69M	813.70M	704.73M	696.72M	639.18M
Total Growth	14.50%	15.46%	1.15%	9.00%	12.16%

Source: S&P Global Market Intelligence.